Journal
EMBO JOURNAL
Volume 31, Issue 3, Pages 517-518Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2011.481
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA116034] Funding Source: Medline
- NIGMS NIH HHS [T32 GM007308] Funding Source: Medline
Ask authors/readers for more resources
Since its description more than two decades ago as a substrate for botulinum C3 exoenzyme (Didsbury et al, 1989), Rac1 has been one of the most studied small GTPases of the Ras superfamily. Interest in Rac1 exploded in 1992 when Ridley and Hall published their seminal work showing that Rac1 regulates the actin cytoskeleton to promote lamellipodia formation (Ridley et al, 1992). Since that report, >4350 studies have been published on Rac1 and seemingly every detail of its regulation and biological function has been dissected, including its post-translational modifications. It therefore comes as somewhat of a surprise when del Pozo and colleagues (Navarro-Lerida et al, 2012) report for the first time in this issue of The EMBO Journal that Rac1 can be palmitoylated and that acylation directs its location in plasma membrane microdomains and modulates its signalling output.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available